Detalles de la búsqueda
1.
Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?
Biol Blood Marrow Transplant
; 26(10): 1759-1769, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32623078
2.
Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.
Cancer
; 126(10): 2183-2192, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32101640
3.
A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy.
Br J Haematol
; 188(3): 404-412, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31468521
4.
Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemia.
Cancer
; 125(21): 3755-3766, 2019 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31310323
5.
Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib.
Am J Hematol
; 94(9): 984-991, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31237017
6.
Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis.
Biol Blood Marrow Transplant
; 24(9): 1920-1927, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29550629
7.
Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML.
Am J Hematol
; 93(1): 65-73, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29023992
8.
Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 23(9): 1478-1484, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28495641
9.
Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell Transplantation.
Transplant Cell Ther
; 30(2): 205.e1-205.e12, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37437764
10.
Matching-Adjusted Indirect Treatment Comparison to Assess the Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 Versus Belantamab Mafodotin in DREAMM-2, Selinexor-Dexamethasone in STORM Part 2, and Melphalan Flufenamide-Dexamethasone in HORIZON for the Treatment of Patients With Triple-Class Exposed Relapsed or Refractory Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 22(9): 690-701, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35764490
11.
Cytogenetic profile of adult AML patients in Turkey: a single center study with comprehensive comparison with literature.
Afr Health Sci
; 22(3): 183-191, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36910358
12.
Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid Leukemia.
Transplant Cell Ther
; 27(8): 689-695, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023569
13.
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity.
Blood Adv
; 5(14): 2799-2806, 2021 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34264268
14.
Copy-number variations in adult patients with chronic immune thrombocytopenia.
Expert Rev Hematol
; 13(11): 1277-1287, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32885695
15.
Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia.
Blood Cancer J
; 10(5): 48, 2020 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32366841
16.
First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate.
Br J Haematol
; 167(1): 139-41, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24815307
17.
Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies.
Drugs
; 79(12): 1287-1304, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31313099
18.
A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome.
Clin Lymphoma Myeloma Leuk
; 18(10): 658-663.e2, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30001986
19.
Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.
Hematology
; 23(4): 212-220, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28990873
20.
Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.
EBioMedicine
; 31: 174-181, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29728305